Showing results (1-10 of 713) with videos related to
Sort By:
Pageof 72
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 2, 2005
Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological markerA J Chamorro, J L Casado, D Bellido, et al.HIV Medicine|July 20, 2019
Evaluation of kidney function in HIV-infected patients receiving an antiretroviral regimen containing one or two inhibitors of the tubular secretion of creatinineJ L Casado, M Monsalvo, P Vizcarra, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 12, 2001
Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapyJ L Casado, R Lopez-Velez, V Pintado, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|September 24, 2013
Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patientsJ L Casado, S Bañon, R Andrés, et al.Journal of Viral Hepatitis|December 6, 2013
Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfectionJ L Casado, C Quereda, A Moreno, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 17, 2013
Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current eraJ L Casado, I Corral, J García, et al.HIV Medicine|July 1, 2015
Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosisJ L Casado, A Mena, S Bañón, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 22, 2014
High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasisA Vallejo, M Abad-Fernández, S Moreno, et al.AIDS Research and Human Retroviruses|February 15, 2001
Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failureJ L Casado, F Dronda, K Hertogs, et al.HIV Medicine|January 22, 2015
Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patientsJ L Casado, M Abad-Fernández, S Moreno, et al.Pageof 72